ALLERGAN INC Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2014 12 months to Dec 31, 2014	FY2013 12 months to Dec 31, 2013	FY2012 12 months to Dec 31, 2012	FY2011 12 months to Dec 31, 2011	FY2010 12 months to Dec 31, 2010
Cash flows from operating activities:
Net earnings
Non-cash items included in net earnings:
Depreciation and amortization
Amortization of original issue discount and debt issuance costs
Amortization of net realized gain on interest rate swaps
Deferred income tax benefit
Loss on disposal and impairment of assets
Loss on extinguishment of convertible debt
Unrealized (gain) loss on derivative instruments
Expense of share-based compensation plans
Intangible asset impairment and related costs
Legal settlement
Loss on sale of discontinued operations
Impairment of intangible assets and related costs
(Income) expense from changes in fair value of contingent consideration
Provision for losses on trade receivables in Venezuela
Restructuring charges
Loss on investments
Pension and other post-retirement benefit plans settlements and curtailments

Changes in operating assets and liabilities:
Trade receivables
Inventories
Other current assets
Other non-current assets
Accounts payable
Accrued expenses
Income taxes
Other liabilities
Net cash provided by operating activities
Cash flows from investing activities:
Purchases of short-term investments
Purchases of equity investments
Acquisitions, net of cash acquired
Additions to property, plant and equipment
Additions to capitalized software
Additions to intangible assets
Contractual purchase price adjustment to prior acquisition
Proceeds from maturities of short-term investments
Proceeds from sale of business
Proceeds from sale of equity investments
Proceeds from sale of business and assets
Proceeds from sale of property, plant and equipment
Net cash provided by (used in) investing activities

Cash flows from financing activities:
Repayments of convertible borrowings
Dividends to stockholders
Payments to acquire treasury stock
Purchase of noncontrolling interest in a subsidiary
Payments of contingent consideration
Net borrowings (repayments) of notes payable
Debt issuance costs
Proceeds from issuance of senior notes, net of discount
Sale of stock to employees
Excess tax benefits from share-based compensation
Net cash (used in) provided by financing activities
Effect of exchange rate changes on cash and equivalents
Net increase in cash and equivalents
Cash and equivalents at beginning of period
Cash and equivalents at end of period
Supplemental disclosure of cash flow information
Cash paid for:
Interest, net of amount capitalized
Income taxes, net of refunds

Comments